TG Therapeutics | TGTX - Caixa e Equivalentes





Caixa e Equivalentes Alterar Data
AbbVie USD 5.23B 400M 2025-12
Alaunos Therapeutics USD 1.94M 941K 2025-09
Amgen USD 9.13B 316M 2025-12
Ardelyx USD 68M 25.28M 2025-12
Arrowhead Research USD 201.64M 112.94M 2025-12
Bayer EUR 5.9B 1.34B 2025-09
Biogen USD 3.01B 854.3M 2025-12
Corcept Therapeutics USD 120.49M 4.64M 2025-12
Curis USD 10.14M 10.14M 2025-06
Gilead Sciences USD 7.33B 2.19B 2025-09
Infinity Pharmaceuticals USD 17.75M 7.99M 2023-06
J&J USD 19.71B 1.48B 2025-12
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
Novartis USD 9.56B 2.9B 2025-09
Novavax USD 240.63M 27.39M 2025-12
PTC Therapeutics USD 984.65M 312.03M 2025-12
Puma Biotechnology USD 53.52M 1.14M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Roche Holding CHF 7.55B 579M 2025-06
TG Therapeutics USD 199.51M 21.2M 2025-12
Verastem USD 204.99M 67.28M 2025-12
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12